Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | BRD4 | O60885 | 1/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | MB | P02144 | 1/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8374421 | 0.89 | LMNA (0.91) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL12781878 | 0.89 | MEN1 (0.70) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL3791417 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL11519910 | 0.87 | ALDH1A1 (0.64) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL7538988 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL25522846 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL13414535 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL8377058 | 0.85 | LMNA (0.56) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL2735596 | 0.85 | MEN1 (0.56) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT | |
| SCHEMBL9807676 | 0.84 | LMNA (1.00) | LMNASMN1; SMN2HSD17B10L3MBTL1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111995527-B | Preparation method of insensitive explosive TATB | 北京理工大学 | 2021-06-04 | — | — | CN | claimed |
| CN-111995527-A | Novel preparation method of insensitive explosive TATB | 北京理工大学 | 2020-11-27 | — | — | CN | claimed |
| US-20250230191-A1 | PEPTIDE LIGANDS FOR BINDING TO MT1-MMP | BICYCLETX LIMITED (GB) | 2025-07-17 | — | — | US | disclosed |
| US-11814447-B2 | Peptide ligands for binding to EphA2 | Bicyclerd Limited (GB) | 2023-11-14 | — | — | US | disclosed |
| US-20230340020-A1 | PEPTIDE LIGANDS FOR BINDING TO MT1-MMP | BICYCLETX LIMITED (GB) | 2023-10-26 | — | — | US | disclosed |
| US-11730819-B2 | Peptide derivatives having novel linkage structures | BICYCLETX LIMITED (GB) | 2023-08-22 | — | — | US | disclosed |
| US-20220194983-A1 | PEPTIDE LIGANDS FOR BINDING TO PSMA | BICYCLETX LIMITED (GB) | 2022-06-23 | — | — | US | disclosed |
| CN-111995527-B | Preparation method of insensitive explosive TATB | 北京理工大学 | 2021-06-04 | — | — | CN | disclosed |
| CN-111995527-A | Novel preparation method of insensitive explosive TATB | 北京理工大学 | 2020-11-27 | — | — | CN | disclosed |
| US-20200316209-A1 | PEPTIDE DERIVATIVES HAVING NOVEL LINKAGE STRUCTURES | BICYCLETX LIMITED (GB) | 2020-10-08 | — | — | US | disclosed |
| EP-1592738-B1 | RESIN COMPOSITIONS | CIBA HOLDING INC (CH) | 2020-07-29 | — | — | EP | disclosed |
| US-8034952-B2 | Supramolecular assemblies and building blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-10-11 | — | — | US | disclosed |
| US-7790793-B2 | Amide nucleating agent compositions | CIBA SPECIALTY CHEM. CORP. (US) | 2010-09-07 | — | — | US | disclosed |
| US-20090143596-A1 | Supramolecular Assemblies and Building Blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2009-06-04 | — | — | US | disclosed |
| US-20070149663-A1 | Resin compositions | CIBA SPECIALTY CHEMICALS CORP. | 2007-06-28 | — | — | US | disclosed |
| EP-1592738-A2 | RESIN COMPOSITIONS | Ciba SC Holding AG (CH) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004072168-A2 | RESIN COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-08-26 | — | — | WO | disclosed |
| US-4157450-A | Benzene-1,3,5-tris-acetoxime and the process for making phloroglucinol therewith | AKZONA INCORPORATED (US) | 1979-06-05 | — | — | US | disclosed |
| US-4115451-A | Benzene-1,3,5-tris-acetoxime and the process for making phloroglucinol therewith | AKZONA INCORPORATED (US) | 1978-09-19 | — | — | US | disclosed |
| US-4071555-A | Benzene-1,3,5-tris-acetoxime and the process for making phloroglucinol therewith | AKZONA INCORPORATED (US) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250230191-A1 | PEPTIDE LIGANDS FOR BINDING TO MT1-MMP | MMP11, MMP3, ANPEP | LMNA 1966/4885SMN1; SMN2 2755/4885HSD17B10 2078/4885 |
| US-11814447-B2 | Peptide ligands for binding to EphA2 | EPHA2, CD2BP2, LNPEP | LMNA 3858/4885SMN1; SMN2 4784/4885HSD17B10 3395/4885 |
| US-20230340020-A1 | PEPTIDE LIGANDS FOR BINDING TO MT1-MMP | MMP11, MMP3, ANPEP | LMNA 1868/4885SMN1; SMN2 2726/4885HSD17B10 2215/4885 |
| US-20200316209-A1 | PEPTIDE DERIVATIVES HAVING NOVEL LINKAGE STRUCTURES | DNPEP, LNPEP, SPPL2B | LMNA 1239/4885SMN1; SMN2 4397/4885HSD17B10 3578/4885 |
| US-11730819-B2 | Peptide derivatives having novel linkage structures | DNPEP, LNPEP, ANPEP | LMNA 1105/4885SMN1; SMN2 4422/4885HSD17B10 3656/4885 |
| US-20220194983-A1 | PEPTIDE LIGANDS FOR BINDING TO PSMA | DNPEP, LNPEP, ANPEP | LMNA 2981/4885SMN1; SMN2 4547/4885HSD17B10 2209/4885 |
| US-20090143596-A1 | Supramolecular Assemblies and Building Blocks | TERB1, TBCB, PARG | LMNA 2486/4885SMN1; SMN2 3515/4885HSD17B10 1716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.